Latest Breaking News On - மருத்துவர்கள் இல்லாமல் எல்லைகள் நுழைவு பிரச்சாரம் - Page 1 : comparemela.com

Novavax Reports Vaccine 90% Effective; Supply Questions Remain Voice of America Another highly effective vaccine is poised to join the fight against COVID-19. But its impact may be blunted by supply issues. The manufacturer expected to produce the bulk of the doses is in India, where the government has banned vaccine exports. Biotech company Novavax announced Monday that its vaccine was 100% effective in preventing severe cases of COVID-19 and 90% effective in preventing any form of the disease in a clinical trial in the United States and Mexico. The company has an agreement to sell 350 million doses to COVAX, the World Health Organization-backed program to improve equitable vaccine access globally. It expects to start delivering shots in the third quarter of 2021, pending approval from regulators.

Johns hopkins universityUnited statesUnited kingdomWest bengalSouth africaTom friedenStanley erckWilliam mossUs centers for diseaseWorld healthAssociated pressJohns hopkins university international vaccine access centerDoctors without borders access campaignSerum institute of indiaWorld health organization backedSerum institute